Neuralink clinical trials: will someone be seriously injured or killed?
9
closes 2025
26%
chance
1D
1W
1M
ALL
Resolves positive 1 month after a credible news report of serious injury or death.
Resolves negative when the clinical trials finish.
Resolves ambiguous if trials are stopped early.
Sort by:
Related markets
Will a human trial published before 2030 show that verteporfin reduces or prevents scarring in humans without serious side effects?61%
Will I be convinced that recreational Ketamine use has worse health effects than alcohol before 2025?17%
Will a large language model (or AI) successfully convince someone to take amphetamine (off-label, not for ADHD) by 2035?61%
Will there be a widely commercially available Cryonics provider that is using aldehyde-stabilized brain preservation protocol by 2025?38%
Will a therapy that substantially slows down or reverses the aging process in humans be developed before 2040?45%
In 2030, will more than 10 million people in the US aged 18+ have tried ketamine in their lifetimes?76%
Will I ingest a psychedelic substance as part of therapy before 2026, if that substance is FDA-approved?38%
Will we get conclusive evidence to prove that ALTO-100 performs better than placebo against Depression and/or PTSD before 2027?20%
Related markets
Will a human trial published before 2030 show that verteporfin reduces or prevents scarring in humans without serious side effects?61%
Will I be convinced that recreational Ketamine use has worse health effects than alcohol before 2025?17%
Will a large language model (or AI) successfully convince someone to take amphetamine (off-label, not for ADHD) by 2035?61%
Will there be a widely commercially available Cryonics provider that is using aldehyde-stabilized brain preservation protocol by 2025?38%
Will a therapy that substantially slows down or reverses the aging process in humans be developed before 2040?45%
In 2030, will more than 10 million people in the US aged 18+ have tried ketamine in their lifetimes?76%
Will I ingest a psychedelic substance as part of therapy before 2026, if that substance is FDA-approved?38%
Will we get conclusive evidence to prove that ALTO-100 performs better than placebo against Depression and/or PTSD before 2027?20%